Ketamine used in the therapy of depressive disorders impacts protein profile, proliferation rate, and phagocytosis resistance of enterococci
Tomasz Jarzembowski
Department of Medical Microbiology, Faculty of Medicine, Medical University of GdanskGdansk, Poland
Orcid profileSearch for this author on
, Agnieszka Daca
Department of Pathology and Experimental Rheumatology, Faculty of Medicine, Medical University of GdanskGdansk, Poland
Orcid profileSearch for this author on
, Wiesław J. Cubała
Department of Psychiatry, Faculty of Medicine, Medical University of GdanskGdansk, Poland
Orcid profileSearch for this author on
, and Aug 09, 2022
About this article